Avi Ashkenazi

5.2k total citations · 1 hit paper
37 papers, 4.3k citations indexed

About

Avi Ashkenazi is a scholar working on Immunology, Molecular Biology and Virology. According to data from OpenAlex, Avi Ashkenazi has authored 37 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 17 papers in Molecular Biology and 8 papers in Virology. Recurrent topics in Avi Ashkenazi's work include Immune Response and Inflammation (14 papers), Immune Cell Function and Interaction (12 papers) and Cell death mechanisms and regulation (10 papers). Avi Ashkenazi is often cited by papers focused on Immune Response and Inflammation (14 papers), Immune Cell Function and Interaction (12 papers) and Cell death mechanisms and regulation (10 papers). Avi Ashkenazi collaborates with scholars based in United States, France and United Kingdom. Avi Ashkenazi's co-authors include Scot A. Marsters, Vishva M. Dixit, Nicholas S. Wilson, Robert Pitti, Peter Schow, David A. Lawrence, Frank Kischkel, Anan Chuntharapai, Minhong Yan and Daniel J. Capon and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Avi Ashkenazi

37 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5

2000 816 citations Peter Schow, Avi Ashkenazi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Avi Ashkenazi United States	26	2.4k	2.3k	813	761	472	37	4.3k
Jens Dhein Germany	13	2.5k 1.0×	2.6k 1.2×	562 0.7×	867 1.1×	590 1.3×	24	4.8k
Keith C. Deen United States	20	1.5k 0.6×	1.7k 0.8×	508 0.6×	750 1.0×	440 0.9×	37	3.6k
Massimo Spada Italy	32	1.8k 0.7×	1.9k 0.8×	761 0.9×	812 1.1×	439 0.9×	58	4.1k
Salvatore Venuta Italy	45	1.4k 0.6×	2.2k 1.0×	757 0.9×	1.6k 2.0×	311 0.7×	137	5.1k
Maria Raffaella Zocchi Italy	45	3.8k 1.6×	1.6k 0.7×	350 0.4×	1.4k 1.8×	321 0.7×	152	6.0k
Abraham Kupfer United States	25	2.8k 1.1×	1.4k 0.6×	489 0.6×	581 0.8×	328 0.7×	44	4.5k
Angelo A. Cardoso United States	38	2.5k 1.0×	2.0k 0.9×	349 0.4×	1.2k 1.6×	276 0.6×	86	5.3k
Rosa Ana Lacalle Spain	30	1.2k 0.5×	2.1k 0.9×	448 0.6×	739 1.0×	238 0.5×	40	3.9k
Maurizio Zanetti United States	36	2.4k 1.0×	1.5k 0.7×	308 0.4×	780 1.0×	597 1.3×	158	4.1k
Pablo Sarobe Spain	39	2.6k 1.1×	1.5k 0.7×	525 0.6×	2.0k 2.6×	935 2.0×	125	5.5k

Countries citing papers authored by Avi Ashkenazi

Since Specialization

Citations

This map shows the geographic impact of Avi Ashkenazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi Ashkenazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi Ashkenazi more than expected).

Fields of papers citing papers by Avi Ashkenazi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avi Ashkenazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi Ashkenazi. The network helps show where Avi Ashkenazi may publish in the future.

Co-authorship network of co-authors of Avi Ashkenazi

This figure shows the co-authorship network connecting the top 25 collaborators of Avi Ashkenazi. A scholar is included among the top collaborators of Avi Ashkenazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avi Ashkenazi. Avi Ashkenazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Filvaroff, Ellen, Jing Peng, Scot A. Marsters, et al.. (2015). MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation. EBioMedicine. 2(5). 406–420. 13 indexed citations

Wilson, Catherine, Xiaofen Ye, Eva Lin, et al.. (2014). AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs. Cancer Research. 74(20). 5878–5890. 116 indexed citations

Ogasawara, Annie, Jeff N. Tinianow, Alexander Vanderbilt, et al.. (2012). ImmunoPET imaging of phosphatidylserine in pro-apoptotic therapy treated tumor models. Nuclear Medicine and Biology. 40(1). 15–22. 18 indexed citations

Wilson, Nicholas S., Vishva M. Dixit, & Avi Ashkenazi. (2009). Death receptor signal transducers: nodes of coordination in immune signaling networks. Nature Immunology. 10(4). 348–355. 439 indexed citations

Daniel, Dylan, Becky Yang, Klára Tótpál, et al.. (2007). Activity of Apomab, a fully human agonistic DR5 monoclonal antibody, in models of non-Hodgkin’s lymphoma. Molecular Cancer Therapeutics. 6. 3 indexed citations

Marsters, Scot A., et al.. (2000). Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Current Biology. 10(13). 785–788. 328 indexed citations

Gurney, Austin, Scot A. Marsters, Arthur Huang, et al.. (1999). Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Current Biology. 9(4). 215–218. 152 indexed citations

Haux, Johan, Bjørg Steinkjer, Unni Nonstad, et al.. (1999). REGULATION OF APO-2 LIGAND/TRAIL EXPRESSION IN NK CELLS—INVOLVEMENT IN NK CELL-MEDIATED CYTOTOXICITY. Cytokine. 11(9). 664–672. 66 indexed citations

Marsters, Scot A., James P. Sheridan, Robert Pitti, et al.. (1998). Identification of a ligand for the death-domain-containing receptor Apo3. Current Biology. 8(9). 525–S2. 158 indexed citations

10.

Marsters, Scot A., Robert Pitti, Christopher J. Donahue, et al.. (1996). Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Current Biology. 6(6). 750–752. 176 indexed citations

11.

Marsters, Scot A., James P. Sheridan, Christopher J. Donahue, et al.. (1996). Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB. Current Biology. 6(12). 1669–1676. 219 indexed citations

12.

Jin, Hua, Renqiang Yang, Scot A. Marsters, et al.. (1995). Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats.. Journal of Clinical Investigation. 95(4). 1947–1952. 24 indexed citations

13.

Bach, Erika A, Susanne J. Szabo, Anand S. Dighe, et al.. (1995). Ligand-Induced Autoregulation of IFN-γ Receptor β Chain Expression in T Helper Cell Subsets. Science. 270(5239). 1215–1218. 181 indexed citations

14.

Haak‐Frendscho, Mary, Scot A. Marsters, Joyce Mordenti, et al.. (1994). Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody.. The Journal of Immunology. 152(3). 1347–1353. 52 indexed citations

15.

Chamow, Steven M., et al.. (1994). A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.. The Journal of Immunology. 153(9). 4268–4280. 27 indexed citations

16.

Jin, H., Ralph T. Yang, Scot A. Marsters, et al.. (1994). Protection Against Rat Endotoxic Shock By p55 Tumor Necrosis Factor (TNF) Receptor Immunoadhesin: Comparison with Anti-TNF Monoclonal Antibody. The Journal of Infectious Diseases. 170(5). 1323–1326. 31 indexed citations

17.

Flasher, Diana, Krystyna Konopka, Steven M. Chamow, et al.. (1994). Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG). Biochimica et Biophysica Acta (BBA) - Biomembranes. 1194(1). 185–196. 24 indexed citations

18.

Chamow, Steven M., Timothy P. Kogan, Michael C. Venuti, et al.. (1994). Modification of CD4 Immunoadhesin with Monomethoxypoly(Ethylene Glycol) Aldehyde via Reductive Alkylation. Bioconjugate Chemistry. 5(2). 133–140. 31 indexed citations

19.

Haak‐Frendscho, Mary, Scot A. Marsters, Steven M. Chamow, et al.. (1993). Inhibition of interferon-gamma by an interferon-gamma receptor immunoadhesin.. PubMed. 79(4). 594–9. 16 indexed citations

20.

Chamow, Steven M., Anne‐Marie Duliège, A. J. Ammann, et al.. (1992). CD4 immunoadhesins in anti-HIV therapy: new developments.. PubMed. 7. 69–72. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact